Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDICINOVA INCMNOV · Entity 7011 | Director | June 23, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDICINOVA INC
Report date June 23, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.36 · Expires 2036-06-22 | Direct | 44,500 |
Reported balance
After 2026-06-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 44,500 · Balance 44,500 F1: The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2026 Filed Jun 25, 2026 20:38 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 44,500 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001683168-26-005111 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 44,500 shares Expires 2036-06-22 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:11 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001683168-25-004651 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-06-16 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2025, December 31, 2025, March 31, 2026 and June 30,2026, subject to continued service with the Company. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:54 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 24,500 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001683168-25-001051 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires 2035-02-11 F1 · derivative.exercise_date: The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12, 2025 and February 12, 2026, subject to continued service with the Company. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 23:41 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001683168-24-004156 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-10 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 22:03 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0001683168-23-004189 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-06-12 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 22:23 UTC | MEDICINOVA INC MNOV · Entity 7011 | SaleCommon Stock | 6,754 | $2.25 | $15,196.50 |
DisclosureSEC source: 0001683168-22-008111 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:01 UTC | MEDICINOVA INC MNOV · Entity 7011 | SaleCommon Stock | 218 | $2.13 | $464.34 |
DisclosureSEC source: 0001683168-22-008020 · ownership.xml · nonDerivative · entry 2 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,754 Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 21:01 UTC | MEDICINOVA INC MNOV · Entity 7011 | SaleCommon Stock | 5,365 | $2.18 | $11,695.70 |
DisclosureSEC source: 0001683168-22-008020 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,972 Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:35 UTC | MEDICINOVA INC MNOV · Entity 7011 | SaleCommon Stock | 309 | $2.18 | $673.62 |
DisclosureSEC source: 0001683168-22-007952 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,337 Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 21:23 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.51 | $0.00 |
DisclosureSEC source: 0001683168-22-004429 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023, subject to continued service with the Company. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 19:48 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001683168-21-002633 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2021, December 31, 2021, March 31, 2022 and June 30, 2022, subject to continued service with the Company. Read SEC document |
| March 11, 2021 Filed Mar 16, 2021 01:30 UTC | MEDICINOVA INC MNOV · Entity 7011 | SaleCommon Stock | 2,354 | $7.40 | $17,419.60 |
DisclosureSEC source: 0001683168-21-000953 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,646 Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 20:32 UTC | MEDICINOVA INC MNOV · Entity 7011 | SaleCommon Stock | 1,000 | $5.78 | $5,780.00 |
DisclosureSEC source: 0001683168-20-003158 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| August 06, 2020 Filed Aug 8, 2020 00:53 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001683168-20-002584 · ownership.xml · derivative · entry 2 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2023-10-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 8, 2020 00:53 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 15,000 | $2.58 | $38,700.00 |
DisclosureSEC source: 0001683168-20-002584 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 22:41 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.70 | $0.00 |
DisclosureSEC source: 0001683168-20-001986 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-15 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2020, December 31, 2020, March 31, 2021 and June 30, 2021, subject to continued service with the Company. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 21:04 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.58 | $0.00 |
DisclosureSEC source: 0001683168-19-001855 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-06-09 F1 · derivative.exercise_date: The option vests in four equal installments on September 10, 2019, December 10, 2019, March 10, 2020 and June 10, 2020, subject to continued service with the Company. Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:41 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $2.77 | $0.00 |
DisclosureSEC source: 0001683168-19-001515 · ownership.xml · derivative · entry 2 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2019-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:41 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 1,000 | $2.77 | $2,770.00 |
DisclosureSEC source: 0001683168-19-001515 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:08 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.34 | $0.00 |
DisclosureSEC source: 0001683168-18-001636 · nagao_f4-060718.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2018, December 31, 2018, March 31, 2019 and June 30, 2019, subject to continued service with the Company. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 22:34 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $6.51 | $0.00 |
DisclosureSEC source: 0001683168-17-002952 · nagao_frm4.xml · derivative · entry 2 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-11-08 F1 · derivative.exercise_date: The option vests in three equal installments on December 31, 2017, March 31, 2018 and June 30, 2018, subject to continued service with the Company. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 22:34 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $6.51 | $0.00 |
DisclosureSEC source: 0001683168-17-002952 · nagao_frm4.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-11-08 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.